Paul Tudor Jones Legend Biotech Corp Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Legend Biotech Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 49,505 shares of LEGN stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,505
Previous 72,060
31.3%
Holding current value
$1.63 Million
Previous $2.44 Million
28.15%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
238Shares Held
59.7MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$227 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$197 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$188 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$124 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$97.3 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.5B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...